Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
about
Clinical Implications of Antiviral Resistance in InfluenzaDiscovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral ResistanceInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceProspective surveillance and molecular characterization of seasonal influenza in a university cohort in SingaporeHow bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public healthTwo years after pandemic influenza A/2009/H1N1: what have we learned?Pandemic influenza: a never-ending story.Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.Influenza outbreaks in Singapore: epidemiology, diagnosis, treatment and prevention.Systematic identification of H274Y compensatory mutations in influenza A virus neuraminidase by high-throughput screening.Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.Cryptoporus volvatus extract inhibits influenza virus replication in vitro and in vivoField monitoring of avian influenza viruses: whole-genome sequencing and tracking of neuraminidase evolution using 454 pyrosequencing.Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.Deep sequencing: becoming a critical tool in clinical virology.Epidemiology of viral respiratory tract infections in an outpatient haematology facility.The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir.
P2860
Q26782746-1D4CE706-36E7-4826-B977-F578E9B07E81Q27316994-B078DDD1-BAFB-4B6E-88F2-5D0D7A0B3134Q28282405-0FC57F09-52A5-457D-B3B0-0A1AB9D334CAQ28539676-FF2F0D95-9153-4766-A0AE-0EA567177A46Q28649612-C8D79259-2270-4D38-A247-13DFE771A920Q30224656-ECCB0F34-5574-4C02-8A47-6E63633AB349Q30353560-D442F776-A42A-4CB4-927D-F492167A4649Q30400621-15CFDCB3-17E1-4ACB-8AF1-DB2B5D102815Q30403699-F5B63B48-4C6E-4678-801A-FEBB6980B66CQ30407719-E7687E5B-E934-48C6-A0BA-0A3AD6FF1703Q30420892-24B011E4-B906-4A51-AB19-C56BD0D3DBA1Q30423620-B4813C06-BD37-4B45-BB91-B253FFFA2A0EQ30432293-5307815D-9B9B-4D6B-B705-B8DDDB681207Q34600066-799F53F6-70D5-40CE-891E-8BE7340025EFQ36172253-6D0AB475-4AB7-4B6F-99D1-1C4A5EE58AE5Q36300881-EEDB7532-7ED8-4196-9EE0-6DF2AC91D595Q38226696-6C49DC0D-2DEC-416B-945E-B376696AB947Q42245439-35805C2D-677C-4127-B53B-9AC1422D58BDQ45323867-EE019331-45B1-43F6-A417-FE01CB832ACBQ47601706-10F90A32-F279-4742-99FF-F72A9FD92E79
P2860
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
@ast
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
@en
type
label
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
@ast
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
@en
prefLabel
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
@ast
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
@en
P2093
P2860
P50
P356
P1476
Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.
@en
P2093
Christopher W Wong
Kwai Peng Chan
Masafumi Inoue
Raphael Tze Chuen Lee
Raymond Lin
Timothy Barkham
P2860
P304
P356
10.3201/EID1610.100688
P577
2010-10-01T00:00:00Z